Hepatitis Research Today is a free monthly online journal that collates and summarizes the latest research about Hepatitis, including details on hepatitis a, b, c, causes, symptoms.

Volume 2 (2007), Issue 4 (April)

1. GSTT1 and GSTM1 null genotypes may facilitate hepatitis C virus infection becoming chronic.
   J Infect Dis, 195(9): 1320-3. [Abstract] [Full-text]
2. CD4+ T cell responses in patients with chronic hepatitis C undergoing peginterferon/ribavirin therapy correlate with faster, but not sustained, viral clearance.
   J Infect Dis, 195(9): 1315-9. [Abstract] [Full-text]
3. Patient-to-patient transmission of hepatitis B virus associated with oral surgery.
   J Infect Dis, 195(9): 1311-4. [Abstract] [Full-text]
4. Molecular epidemiology of hepatitis A virus in a group of Portuguese citizens living in Lisbon area.
   J Med Virol, 79(5): 483-7. [Abstract] [Full-text]
5. Involvement of dendritic cell frequency and function in virological relapse in pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C patients.
   J Med Virol, 79(5): 511-21. [Abstract] [Full-text]
6. Influence of HCV genotype and co-infection with human immunodeficiency virus on CD4(+) and CD8(+) T-cell responses to hepatitis C virus.
   J Med Virol, 79(5): 503-10. [Abstract] [Full-text]
7. Different transmission patterns of hepatitis A virus for two main risk groups as evidenced by molecular cluster analysis.
   J Med Virol, 79(5): 488-94. [Abstract] [Full-text]
8. Utilizing self-prepared ELISA plates for a cross-population study of different anti-HBe IgG subclass profiles.
   J Med Virol, 79(5): 495-502. [Abstract] [Full-text]
9. Long-term immunogenicity of hepatitis B vaccination in a cohort of Italian healthy adolescents.
   Vaccine, 25(16): 3129-32. [Abstract] [Full-text]
10. Impact of hepatitis B vaccination in a highly endemic area of south Italy and long-term duration of anti-HBs antibody in two cohorts of vaccinated individuals.
    Vaccine, 25(16): 3133-6. [Abstract] [Full-text]
11. Current therapy for autoimmune hepatitis.
    Nat Clin Pract Gastroenterol Hepatol, 4(4): 202-14. [Abstract] [Full-text]
12. Baicalin protects mouse from Concanavalin A-induced liver injury through inhibition of cytokine production and hepatocyte apoptosis.
    Liver Int, 27(4): 582-91. [Abstract] [Full-text]
13. Consequences of treatment withdrawal in type 1 autoimmune hepatitis.
    Liver Int, 27(4): 507-15. [Abstract] [Full-text]
14. Drug-induced liver injury at an Asian center: a prospective study.
    Liver Int, 27(4): 465-74. [Abstract] [Full-text]
15. Successful treatment with etanercept in a patient with hepatotoxicity closely related to infliximab.
    Clin Rheumatol, 26(5): 811-3. [Abstract] [Full-text]
16. Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection.
    Clin Infect Dis, 44(9): 1161-9. [Abstract] [Full-text]
17. Acute hepatitis with severe cholestasis and prolonged clinical course due to hepatitis A virus Ia and Ib coinfection.
    Clin Infect Dis, 44(9): e73-7. [Abstract] [Full-text]
18. Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: a systematic review.
    Br J Cancer, 96(7): 1127-34. [Abstract] [Full-text]
19. New hepatitis B vaccine formulated with an improved adjuvant system.
    Expert Rev Vaccines, 6(2): 133-40. [Abstract] [Full-text]
20. Update on viral hepatitis: 2006.
    Curr Opin Gastroenterol, 23(3): 263-7. [Abstract] [Full-text]
21. Autoimmune liver disease.
    Curr Opin Gastroenterol, 23(3): 255-62. [Abstract] [Full-text]
22. Analysis of the complete genomic sequence of an apparently avirulent strain of avian hepatitis E virus (avian HEV) identified major genetic differences compared with the prototype pathogenic strain of avian HEV.
    J Gen Virol, 88: 1538-44. [Abstract] [Full-text]
23. Egg whites from eggs of chickens infected experimentally with avian hepatitis E virus contain infectious virus, but evidence of complete vertical transmission is lacking.
    J Gen Virol, 88: 1532-7. [Abstract] [Full-text]
24. Complete genomes for hepatitis C virus subtypes 6f, 6i, 6j and 6m: viral genetic diversity among Thai blood donors and infected spouses.
    J Gen Virol, 88: 1505-18. [Abstract] [Full-text]
25. Cyclic monophosphate prodrugs of base-modified 2'-C-methyl ribonucleosides as potent inhibitors of hepatitis C virus RNA replication.
    Bioorg Med Chem Lett, 17(9): 2452-5. [Abstract] [Full-text]
26. 6-Hydrazinopurine 2'-methyl ribonucleosides and their 5'-monophosphate prodrugs as potent hepatitis C virus inhibitors.
    Bioorg Med Chem Lett, 17(9): 2456-8. [Abstract] [Full-text]
27. Hepatitis B virus genotypes and lamivudine resistance mutations in HIV/hepatitis B virus-coinfected patients.
    J Acquir Immune Defic Syndr, 44(5): 557-61. [Abstract] [Full-text]
28. Early initiation of antiretroviral therapy: the current best way to reduce liver-related deaths in HIV/hepatitis C virus-coinfected patients.
    J Acquir Immune Defic Syndr, 44(5): 551-6. [Abstract] [Full-text]
29. Prophylaxis and treatment of hepatitis B in immunocompromised patients.
    Dig Liver Dis, 39(5): 397-408. [Abstract] [Full-text]
30. Essential hypertension and chronic viral hepatitis.
    Dig Liver Dis, 39(5): 466-72. [Abstract] [Full-text]
31. Arsenic induces apoptosis in mouse liver is mitochondria dependent and is abrogated by N-acetylcysteine.
    Toxicol Appl Pharmacol, 220(2): 146-55. [Abstract] [Full-text]
32. Isolated hepatitis B core antibody is associated with HIV and ongoing but not resolved hepatitis C virus infection in a cohort of US women.
    J Infect Dis, 195(10): 1437-42. [Abstract] [Full-text]
33. Benefits and adverse effects of hepatitis C screening: early results of a screening program.
    J Public Health Manag Pract, 13(3): 263-9. [Abstract] [Full-text]
34. Inhibition of viral replication reduces regulatory T cells and enhances the antiviral immune response in chronic hepatitis B.
    Virology, 361(1): 141-8. [Abstract] [Full-text]
35. Hepatitis C virus infects T cells and affects interferon-gamma signaling in T cell lines.
    Virology, 361(1): 161-73. [Abstract] [Full-text]
36. A reduction in selective immune pressure during the course of chronic hepatitis C correlates with diminished biochemical evidence of hepatic inflammation.
    Virology, 361(1): 27-33. [Abstract] [Full-text]
37. Impact of hepatitis C on HIV progression in adults with alcohol problems.
    Alcohol Clin Exp Res, 31(5): 829-36. [Abstract] [Full-text]
38. Oral lichen planus and chronic hepatitis C: a controversial association.
    Am J Clin Pathol, 127(5): 800-4. [Abstract] [Full-text]
39. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases.
    J Viral Hepat, 14(5): 360-9. [Abstract] [Full-text]
40. SEN virus co-infection among HCV-RNA-positive mothers, risk of transmission to the offspring and outcome of child infection during a 1-year follow-up.
    J Viral Hepat, 14(5): 355-9. [Abstract] [Full-text]
41. Prolonged antiviral therapy for hepatitis B virus-infected health care workers: a feasible option to prevent work restriction without jeopardizing patient safety.
    J Viral Hepat, 14(5): 350-4. [Abstract] [Full-text]
42. Correlation of amino acid variations within nonstructural 4B protein with initial viral kinetics during interferon-alpha-based therapy in HCV-1b-infected patients.
    J Viral Hepat, 14(5): 338-49. [Abstract] [Full-text]
43. Clinical responders to antiviral therapy of chronic HCV infection show elevated antiviral CD4+ and CD8+ T-cell responses.
    J Viral Hepat, 14(5): 318-29. [Abstract] [Full-text]
44. Hepatitis E virus infection among animals in northern India: an unlikely source of human disease.
    J Viral Hepat, 14(5): 310-7. [Abstract] [Full-text]
45. Autochthonous hepatitis E in southwest England.
    J Viral Hepat, 14(5): 304-9. [Abstract] [Full-text]
46. Fulminant liver failure from acute autochthonous hepatitis E in France: description of seven patients with acute hepatitis E and encephalopathy.
    J Viral Hepat, 14(5): 298-303. [Abstract] [Full-text]
47. Musculoskeletal complaints and serum autoantibodies associated with chronic hepatitis C and nonalcoholic fatty liver disease.
    Dig Dis Sci, 52(5): 1177-82. [Abstract] [Full-text]
48. Reasons why patients infected with chronic hepatitis C virus choose to defer treatment: do they alter their decision with time?
    Dig Dis Sci, 52(5): 1168-76. [Abstract] [Full-text]
49. Heterozygous beta-globin gene mutations as a risk factor for iron accumulation and liver fibrosis in chronic hepatitis C.
    Gut, 56(5): 693-8. [Abstract] [Full-text]
50. Predicting response to peginterferon alpha-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis B.
    Gut, 56(5): 699-705. [Abstract] [Full-text]
51. The effect of multiple doses of peginterferon alfa-2b on the steady-state pharmacokinetics of methadone in patients with chronic hepatitis C undergoing methadone maintenance therapy.
    J Clin Pharmacol, 47(5): 604-12. [Abstract] [Full-text]
52. Liver injury induced by a Japanese herbal medicine, sairei-to (TJ-114, Bupleurum and Hoelen Combination, Chai-Ling-Tang) R1.
    J Gastroenterol Hepatol, 22(5): 762-3. [Abstract] [Full-text]
53. Oxidative-inflammatory damage in cirrhosis: effect of vitamin E and a fermented papaya preparation.
    J Gastroenterol Hepatol, 22(5): 697-703. [Abstract] [Full-text]
54. Hepatitis E virus infection and fulminant hepatic failure during pregnancy.
    J Gastroenterol Hepatol, 22(5): 676-82. [Abstract] [Full-text]
55. Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy.
    J Gastroenterol Hepatol, 22(5): 669-75. [Abstract] [Full-text]
56. Peginterferon alpha-2a (40 KD) plus ribavirin for the treatment of chronic hepatitis C in Japanese patients.
    J Gastroenterol Hepatol, 22(5): 645-52. [Abstract] [Full-text]
57. Beneficial effects of pentoxifylline on hepatic steatosis, fibrosis and necroinflammation in patients with non-alcoholic steatohepatitis.
    J Gastroenterol Hepatol, 22(5): 634-8. [Abstract] [Full-text]
58. Impact of hepatitis A vaccination on health care utilization in the United States, 1996-2004.
    Vaccine, 25(18): 3581-7. [Abstract] [Full-text]
59. Mathematical model of the antibody response to hepatitis B vaccines: implications for reduced schedules.
    Vaccine, 25(18): 3705-12. [Abstract] [Full-text]
60. SeqHepB: a sequence analysis program and relational database system for chronic hepatitis B.
    Antiviral Res, 75(1): 64-74. [Abstract] [Full-text]
61. Direct evidence for immunomodulatory properties of ribavirin on T-cell reactivity to hepatitis C virus.
    Antiviral Res, 75(1): 36-42. [Abstract] [Full-text]
62. CD81 down-regulation on B cells is associated with the response to interferon-alpha-based treatment for chronic hepatitis C virus infection.
    Antiviral Res, 75(1): 43-51. [Abstract] [Full-text]
63. Hepatitis A virus infection in people of South Asian origin in England and Wales: analysis of laboratory reports between 1992 and 2004.
    Epidemiol Infect, 135(4): 549-54. [Abstract] [Full-text]
64. Precore and core promoter mutations at the time of HBeAg seroclearance in Chinese patients with chronic hepatitis B.
    J Infect, 54(5): 497-503. [Abstract] [Full-text]
65. Hepatitis C virus: laboratory surveillance in England and Wales, 1992-2004.
    Epidemiol Infect, 135(4): 541-8. [Abstract] [Full-text]
66. Replacement of hepatitis C virus genotype 1b by genotype 2 over a 10-year period in Venezuela.
    J Clin Gastroenterol, 41(5): 518-20. [Abstract] [Full-text]
67. Hepatic steatosis has no impact on the outcome of treatment in patients with chronic hepatitis B infection.
    J Clin Gastroenterol, 41(5): 513-7. [Abstract] [Full-text]
68. Outcomes after lung transplantation in patients with chronic hepatitis C virus infection.
    J Heart Lung Transplant, 26(5): 466-71. [Abstract] [Full-text]
69. Ten-year antibody persistence induced by hepatitis A and B vaccine (Twinrix) in adults.
    Travel Med Infect Dis, 5(3): 171-5. [Abstract] [Full-text]
70. The impact of state policies on vaccine coverage by age 13 in an insured population.
    J Adolesc Health, 40(5): 405-11. [Abstract] [Full-text]
71. Effect of interleukin-10 on tissue damage caused by organophosphate poisoning.
    Basic Clin Pharmacol Toxicol, 100(5): 323-7. [Abstract] [Full-text]
72. Influence of different atropine therapy strategies on fenthion-induced organ dysfunction in rats.
    Basic Clin Pharmacol Toxicol, 100(5): 308-15. [Abstract] [Full-text]
73. Assessing routine and serum markers of liver fibrosis in CHB patients using parallel and serial interpretation.
    Clin Biochem, 40(8): 562-6. [Abstract] [Full-text]
74. Kava feeding in rats does not cause liver injury nor enhance galactosamine-induced hepatitis.
    Food Chem Toxicol, 45(7): 1293-300. [Abstract] [Full-text]
75. Using improved technology for filter paper-based blood collection to survey wild Sika deer for antibodies to hepatitis E virus.
    J Virol Methods, 142(1): 143-50. [Abstract] [Full-text]
76. Flowcytometric quantitation of hepatitis B viral antigens in hepatocytes from regular and fine-needle biopsies.
    J Virol Methods, 142(1): 189-97. [Abstract] [Full-text]
77. Intrahepatic interleukin-8 production during disease progression of chronic hepatitis C.
    Cancer Lett, 251(1): 36-42. [Abstract] [Full-text]
78. Progression to end-stage liver disease in patients with inherited bleeding disorders and hepatitis C: an international, multicenter cohort study.
    Blood, 109(9): 3667-71. [Abstract] [Full-text]
79. Hazardous alcohol consumption and other barriers to antiviral treatment among hepatitis C positive people receiving opioid maintenance treatment.
    Drug Alcohol Rev, 26(3): 231-9. [Abstract] [Full-text]
80. A review of the hepatotoxic plant Lantana camara.
    Crit Rev Toxicol, 37(4): 313-52. [Abstract] [Full-text]
81. Hepatitis B virus seropositivity and the risk of stroke and myocardial infarction.
    Stroke, 38(5): 1436-41. [Abstract] [Full-text]
82. Risk of hepatitis B infections in Olympic wrestling.
    Br J Sports Med, 41(5): 306-10; discussion 310. [Abstract] [Full-text]
83. Non-injection drug use and Hepatitis C Virus: a systematic review.
    Drug Alcohol Depend, 89(1): 1-12. [Abstract] [Full-text]
84. Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours.
    AIDS, 21(8): 983-91. [Abstract] [Full-text]
85. First case of hepatitis C virus transmission by a red blood cell concentrate after introduction of nucleic acid amplification technique screening in Germany: a comparative study with various assays.
    Vox Sang, 92(4): 297-301. [Abstract] [Full-text]
86. Trends of hepatitis A hospitalization and risk factors in Quebec, Canada, between 1990 and 2003.
    BMC Infect Dis, 7: 31. [Abstract] [Full-text]
87. Genes associated with progression and recurrence of hepatocellular carcinoma in hepatitis C patients waiting and undergoing liver transplantation: preliminary results.
    Transplantation, 83(7): 973-81. [Abstract] [Full-text]
88. Elevated interleukin-4 expression in severe recurrent hepatitis C virus after liver transplantation.
    Transplantation, 83(7): 906-11. [Abstract] [Full-text]
89. Hepatitis C virus infection and kidney transplantation: predictors of patient and graft survival.
    Transplantation, 83(7): 853-7. [Abstract] [Full-text]
90. Association between hepatitis C virus coinfection and regional adipose tissue volume in HIV-infected men and women.
    J Acquir Immune Defic Syndr, 45(1): 60-5. [Abstract] [Full-text]
91. Urinary 8-oxodeoxyguanosine, aflatoxin B1 exposure and hepatitis B virus infection and hepatocellular carcinoma in Taiwan.
    Carcinogenesis, 28(5): 995-9. [Abstract] [Full-text]
92. A weak association between occult HBV infection and non-B non-C hepatocellular carcinoma in Japan.
    J Gastroenterol, 42(4): 298-305. [Abstract] [Full-text]
93. Decrease and dysfunction of dendritic cells correlate with impaired hepatitis C virus-specific CD4+ T-cell proliferation in patients with hepatitis C virus infection.
    Immunology, 121(2): 283-92. [Abstract] [Full-text]
94. Hepatitis B virus splice-generated protein induces T-cell responses in HLA-transgenic mice and hepatitis B virus-infected patients.
    J Virol, 81(10): 4963-72. [Abstract] [Full-text]
95. Rift Valley fever virus lacking NSm proteins retains high virulence in vivo and may provide a model of human delayed onset neurologic disease.
    Virology, 362(1): 10-5. [Abstract] [Full-text]
96. Severe acute hepatitis related to hydroxychloroquine in a woman with mixed connective tissue disease.
    Clin Rheumatol, 26(6): 971-2. [Abstract] [Full-text]

© 2006-2008 Hepatitis Research Today. All Rights Reserved.